Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

European Society of Cardiology

This page shows the latest European Society of Cardiology news and features for those working in and with pharma, biotech and healthcare.

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

Earlier this month, AZ revealed the results of the DAPA-HF trial of its diabetes therapy Farxiga, to an eager crowd at the European Society of Cardiology. ... This hard-to-treat form of the disease currently has no approved drug therapies.

Latest news

  • AZ’s Farxiga heart failure results wow the ESC AZ’s Farxiga heart failure results wow the ESC

    Lead investigator John McMurray of the University of Glasgow presented the results at the European Society of Cardiology (ESC) congress in Paris over the weekend to an enthusiastic audience. ... non-diabetic population and make it an option for the

  • TMC rockets on data for twice-yearly cholesterol drug inclisiran TMC rockets on data for twice-yearly cholesterol drug inclisiran

    The results will be presented at the European Society of Cardiology meeting in Paris next week. ... control the LDL-cholesterol levels despite maximum doses of statin drugs, with or without Merck &Co’s add-on therapy Zetia (ezetimibe).

  • Blow for Entresto in latest heart failure trial Blow for Entresto in latest heart failure trial

    In November last year it also gained FDA Fast Track Designation for praliciguat for the treatment of HFpEF. ... Novartis will present new data on cardiac remodeling at the European Society of Cardiology (ESC) congress 2019, and more detailed resilts from

  • Real-world data finds patients feel better on Entresto, says Novartis Real-world data finds patients feel better on Entresto, says Novartis

    The real-world data - reported at the European Society of Cardiology Heart Failure (ESC-HF) Congress over the weekend - comes from the CHAMP-HF registry of heart failure patients and specifically ... According to CHAMP-HF Chair Gregg Fonarow of UCLA's

  • FDA approves first Apple Watch medical device accessory FDA approves first Apple Watch medical device accessory

    In September, AliveCor presented data from studies at the European Society of Cardiology Congress In Barcelona showing that patients using Kardia Mobile were four times more likely to have their AF ... detected, and that the diagnostic accuracy of the

More from news
Approximately 2 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Is it possible to change behaviour virtually? Is it possible to change behaviour virtually?

    One of my colleagues, Emma, has also incorporated virtual technology into a medical education programme. ... What value did the virtual mannequin add?  . It was the first time ever a virtual mannequin had been used at the European Society of Cardiology

  • Helping European cardiologists keep up to date Helping European cardiologists keep up to date

    But when asked about their propensity to take part in programmes in relation to: (1) the sponsoring organisation (independent bodies such as the European Society of Cardiology or an unrestricted grant ... Figure 4: EU5 average of preferences of online

  • Change drivers: multi-stakeholder education and collaboration Change drivers: multi-stakeholder education and collaboration

    Professor John Camm, Chair of the European Society of Cardiology Committee for Guidelines on the Management of Atrial Fibrillation told me recently: “Well-meaning rewording of key messages to 'suit' different ... It resulted in improved cholesterol

  • Closing the treatment gap

    Timescale:March 2009 to August 2009. The annual European Society of Cardiology Congress is the largest global cardiology meeting, attracting thousands of delegates and hundreds of journalists; the competition between pharmaceutical ... Merck, with a

  • A very favourable verdict

    Timescale:July 2009 to December 2009. Guest delegates of DAIICHI SANKYO UK at the European Society of Cardiology Congress were subpoenaed to appear on a jury at The Formulary Court of ... meetings and will also roll out via a series of regional GP

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Conference research case study

    Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress. ... meant to our clients key customers and the overall impact of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Quick links

Infographics

Multimedia